Leading translational genomics and personalized diagnostics company headquartered in Pleasanton, California with significant business operations in China.
DIACARTA provides advanced and highly sensitive technologies that will change the landscape of precision medicine and molecular diagnostics by impacting healthcare treatment plans and the well-being of people around the world